Predictors and outcomes of dose reduction of methotrexate and cyclosporin <scp>graft‐versus‐host disease</scp> prophylaxis following allogeneic haemopoietic cell transplantation-Reference-Cited by-同舟云学术

Predictors and outcomes of dose reduction of methotrexate and cyclosporin graft‐versus‐host disease prophylaxis following allogeneic haemopoietic cell transplantation

Published:2022-09-06 Issue: Volume: Page:
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:Internal Medicine Journal

Author:

Ramanan Radha¹^ORCID,Lim Andrew B. M.²^ORCID,Tan Joanne L. C.³,Barmanray Rahul D.⁴^ORCID,Mason Kate²,Collins Jenny¹,Hillman Matthew¹,Szer Jeff¹⁴^ORCID,Bajel Ashish¹⁵,Ritchie David¹⁴

Affiliation:

1. Department of Clinical Haematology Peter MacCallum Cancer Centre and The Royal Melbourne Hospital Melbourne Victoria Australia

2. Department of Clinical Haematology and Olivia Newton John Cancer Research Institute Austin Health Melbourne Victoria Australia

3. Department of Haematology Alfred Health Melbourne Victoria Australia

4. Department of Medicine, Dentistry and Health Sciences The University of Melbourne Melbourne Victoria Australia

5. Sir Peter MacCallum Department of Oncology University of Melbourne Melbourne Victoria Australia

Publisher

Wiley

Subject

Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imj.15829

Reference31 articles.

1. Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantation

2. Pathophysiology of acute graft-versus-host disease

3. Influence of acute and chronic graft‐versus‐host disease on relapse and survival after bone marrow transplantation from HLA‐identical siblings as treatment of acute and chronic leukemia;Weiden PL;Blood,1989

4. Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate [see comments]

5. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia;Storb R;J Med,1986